Work

Quantifying factors for the success of stratified medicine

Year: 2011

Type: review

Source: Nature Reviews Drug Discovery

DOI: 10.1038/nrd3557

Authors: Mark R. Trusheim, Breon Burgess, Sean Xinghua Hu, Theresa Long, Steven D. Averbuch, Aiden A. Flynn, Alfons Lieftucht, Abhijit Mazumder, Judy Milloy, Peter M. Shaw, David Swank, Jian Wang, Ernst R. Berndt, Federico Goodsaid, Michael C. Palmer

Institutions: Massachusetts Institute of Technology, Merck & Co., Inc., Rahway, NJ, USA (United States), BGI Group (China), Chinese Academy of Sciences, Chinese National Human Genome Center at Shanghai, IQVIA (United States), Van Andel Institute, Bristol-Myers Squibb (United States), Johnson & Johnson (United States), GlaxoSmithKline (United Kingdom), Eli Lilly (United States), United States Food and Drug Administration, New York University

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1986403099

FWCI: 5.054

Cites: 54

Cited by: 102

Related to: 10